Background: To evaluate whether a model based on radiomic and clinical features may be associated with lymph node (LN) status and overall survival (OS) in lung cancer (LC) patients; to evaluate whether CT reconstruction algorithms may influence the model performance. Methods: patients operated on for LC with a pathological stage up to T3N1 were retrospectively selected and divided into training and validation sets. For the prediction of positive LNs and OS, the Least Absolute Shrinkage and Selection Operator (LASSO) logistic regression model was used; univariable and multivariable logistic regression analysis assessed the association of clinical-radiomic variables and endpoints. All tests were repeated after dividing the groups according to...
Loco-regional control (LRC) is a major clinical endpoint after definitive radiochemotherapy (RCT) of...
Background and purpose: The prognostic value of radiomics for non-small cell lung cancer (NSCLC) pat...
Purpose: We aimed to assess the ability of radiomics features extracted from baseline (PET/CT0) and ...
Background: We evaluated the role of radiomics applied to contrast-enhanced computed tomography (CT)...
Background Radiomics is a promising tool for the identification of new prognostic biomarkers. Rad...
Purpose: We investigated whether a fluorine-18-fluorodeoxy glucose positron emission tomography/comp...
Radiomics is a promising tool for the identification of new prognostic biomarkers. Radiomic features...
This study aimed to create a risk score generated from CT-based radiomics signatures that could be u...
BACKGROUND No evidence supports the choice of specific imaging filtering methodologies in radiomi...
Objectives: Recently it has been shown that radiomic features of computed tomography (CT) have progn...
Introduction:Accurate assessment of lymph node (LN) involvement with malignancy is critical to stagi...
Lung cancer is the leading cause of cancer-related death in the United States and worldwide. Early ...
Introduction: Despite radical intent therapy for patients with stage III non-small-cell lung cancer ...
Loco-regional control (LRC) is a major clinical endpoint after definitive radiochemotherapy (RCT) of...
Background and purpose: The prognostic value of radiomics for non-small cell lung cancer (NSCLC) pat...
Purpose: We aimed to assess the ability of radiomics features extracted from baseline (PET/CT0) and ...
Background: We evaluated the role of radiomics applied to contrast-enhanced computed tomography (CT)...
Background Radiomics is a promising tool for the identification of new prognostic biomarkers. Rad...
Purpose: We investigated whether a fluorine-18-fluorodeoxy glucose positron emission tomography/comp...
Radiomics is a promising tool for the identification of new prognostic biomarkers. Radiomic features...
This study aimed to create a risk score generated from CT-based radiomics signatures that could be u...
BACKGROUND No evidence supports the choice of specific imaging filtering methodologies in radiomi...
Objectives: Recently it has been shown that radiomic features of computed tomography (CT) have progn...
Introduction:Accurate assessment of lymph node (LN) involvement with malignancy is critical to stagi...
Lung cancer is the leading cause of cancer-related death in the United States and worldwide. Early ...
Introduction: Despite radical intent therapy for patients with stage III non-small-cell lung cancer ...
Loco-regional control (LRC) is a major clinical endpoint after definitive radiochemotherapy (RCT) of...
Background and purpose: The prognostic value of radiomics for non-small cell lung cancer (NSCLC) pat...
Purpose: We aimed to assess the ability of radiomics features extracted from baseline (PET/CT0) and ...